Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H22N2OS |
| Molecular Weight | 314.445 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(SC3=C(C=CC=C3)N2CCCN(C)C)C=C1
InChI
InChIKey=BRABPYPSZVCCLR-UHFFFAOYSA-N
InChI=1S/C18H22N2OS/c1-19(2)11-6-12-20-15-7-4-5-8-17(15)22-18-10-9-14(21-3)13-16(18)20/h4-5,7-10,13H,6,11-12H2,1-3H3
| Molecular Formula | C18H22N2OS |
| Molecular Weight | 314.445 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/13489953
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13489953
Methopromazine was developed as a neuroleptic agent with antipsychotic activity. Information about the current use of this compound is not available.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Application of methopromazine for the extractive spectrophotometric determination of platinum. | 1983-07 |
|
| [Methopromazine and adrenalin vasodilatation]. | 1961 |
|
| [Pharmacological study of a new derivative of phenothiazine, 4632 RP or methopromazine]. | 1957 |
|
| [Pharmacodynamic properties of methopromazine, new neuroleptic related to chlorpromazine]. | 1957 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:17:54 GMT 2025
by
admin
on
Mon Mar 31 19:17:54 GMT 2025
|
| Record UNII |
A6F645Q9HQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
18847
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
592
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
100000081454
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110655
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
m825
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | Merck Index | ||
|
A6F645Q9HQ
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
SUB08854MIG
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
C008393
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
1756
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
DTXSID90209843
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
C174606
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
61-01-8
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY | |||
|
200-497-6
Created by
admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |